Equity Overview
Price & Market Data
Price: $2.43
Daily Change: -$0.155 / 6.38%
Daily Range: $2.39 - $2.70
Market Cap: $87,950,208
Daily Volume: 14,219
Performance Metrics
1 Week: -0.82%
1 Month: 9.46%
3 Months: 76.09%
6 Months: 20.30%
1 Year: -10.99%
YTD: 31.35%
Company Details
Employees: 60
Sector: Health technology
Industry: Biotechnology
Country:
Details
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.